Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis

BACKGROUND: Fibulin-3 (FBLN3) was recently presented as a promising novel biomarker for malignant pleural mesothelioma (MPM), warranting independent validation studies. METHODS: ELISA was used to measure cellular and secreted FBLN3 in cell lines, in plasma of xenograft tumour-bearing mice, in plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirschner, Michaela B, Pulford, Emily, Hoda, Mir Alireza, Rozsas, Anita, Griggs, Kim, Cheng, Yuen Yee, Edelman, J James B, Kao, Steven C, Hyland, Rebecca, Dong, Yawen, László, Viktoria, Klikovits, Thomas, Vallely, Michael P, Grusch, Michael, Hegedus, Balazs, Dome, Balazs, Klepetko, Walter, van Zandwijk, Nico, Klebe, Sonja, Reid, Glen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578085/
https://www.ncbi.nlm.nih.gov/pubmed/26263483
http://dx.doi.org/10.1038/bjc.2015.286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578085/
https://www.ncbi.nlm.nih.gov/pubmed/26263483
http://dx.doi.org/10.1038/bjc.2015.286

Ejemplares similares